Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Platinum-resistant Peritoneal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04556071
What this trial is testing

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsEndocrine Gland Neoplasms+21 more
Xiaoxiang Chen 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05465941
What this trial is testing

PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+3 more
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT00888615
What this trial is testing

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
GOG Foundation 58
Testing effectiveness (Phase 2)Ended earlyNCT04019288
What this trial is testing

AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00109096
What this trial is testing

Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy

Who this might be right for
Ovarian NeoplasmsPrimary Peritoneal Cancer
Eli Lilly and Company 100
Early research (Phase 1)Study completedNCT03030287
What this trial is testing

A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer

Who this might be right for
Cancer OvariesCancer PeritonealCancer, Fallopian Tube
OncoMed Pharmaceuticals, Inc. 44
Large-scale testing (Phase 3)Not Yet RecruitingNCT06751485
What this trial is testing

JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary PeritonealFallopian Tube Cancers
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 430
Large-scale testing (Phase 3)Not Yet RecruitingNCT06867562
What this trial is testing

Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

Who this might be right for
Platinum-Resistant Primary Peritoneal CarcinomaPlatinum Resistant High Grade Epithelial Ovarian CancerPlatinum Resistant High Grade Serous Ovarian Cancer
Jina Pharmaceuticals Inc. 166
Testing effectiveness (Phase 2)WithdrawnNCT06545617
What this trial is testing

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Who this might be right for
Platinum-resistant Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Bio-Thera Solutions
Very early researchActive Not RecruitingNCT05053750
What this trial is testing

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Epithelial OvarianFallopian TubePrimary Peritoneal Cancer
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT01175343
What this trial is testing

RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+3 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT02759588
What this trial is testing

Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CarcinomatosisFallopian Tube Cancer
Genelux Corporation 46
Testing effectiveness (Phase 2)Ended earlyNCT00526799
What this trial is testing

Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Daniela Matei, MD 30
Large-scale testing (Phase 3)Looking for participantsNCT07218809
What this trial is testing

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
AstraZeneca 1,100
Testing effectiveness (Phase 2)WithdrawnNCT05295589
What this trial is testing

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+9 more
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT04678102
What this trial is testing

Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian CarcinomaPlatinum-Resistant Fallopian Tube Carcinoma+1 more
Seoul National University Hospital 36
Large-scale testing (Phase 3)WithdrawnNCT03632798
What this trial is testing

Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Cordgenics, LLC
Testing effectiveness (Phase 2)Study completedNCT00317772
What this trial is testing

Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPeritoneal NeoplasmsFallopian Tube Cancer
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00436644
What this trial is testing

Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 18
Early research (Phase 1)Ended earlyNCT02661815
What this trial is testing

A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Dana-Farber Cancer Institute 6
Next Page